These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 36791634)

  • 1. Diabetes, Ramadan, and driving - Ensuring patient safety while respecting religious autonomy: A qualitative study.
    Tan CSS; Wong YJ; Tang KF; Lee SWH
    Diabetes Metab Syndr; 2023 Feb; 17(2):102724. PubMed ID: 36791634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimizing Ramadan fasting: A randomised controlled trial for people with type 2 diabetes during Ramadan applying the principles of the ADA/EASD consensus.
    Ibrahim M; Barker MM; Ahmad E; Ahmed A; Annabi FA; Ba-Essa EM; Davies MJ; Houeiss P; Iraqi H; Masood SN; Mimouni-Zerguini S; Shaikh S; Tantawi H; Tuomilehto J
    Diabetes Metab Res Rev; 2023 Mar; 39(3):e3604. PubMed ID: 36547366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of COVID-19 on Ramadan fasting in people with diabetes in East London 2020: The East London diabetes in Ramadan survey.
    Khan H; Chowdhury A; Lasker SS; Chowdhury TA
    Diabetes Res Clin Pract; 2020 Nov; 169():108476. PubMed ID: 33002549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Real-world safety and effectiveness of iGlarLixi in people with type 2 diabetes who fast during Ramadan: The SoliRam observational study.
    Hassanein M; Malek R; Shaltout I; Sahay RK; Buyukbese MA; Djaballah K; Pilorget V; Coudert M; Al Sifri S;
    Diabetes Metab Syndr; 2023 Feb; 17(2):102707. PubMed ID: 36680967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perspectives and experiences of patients with type 2 diabetes observing the Ramadan fast.
    Almansour HA; Chaar B; Saini B
    Ethn Health; 2018 May; 23(4):380-396. PubMed ID: 27998181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Attitude and safety of patients with diabetes observing the Ramadan fast.
    Ba-Essa EM; Hassanein M; Abdulrhman S; Alkhalifa M; Alsafar Z
    Diabetes Res Clin Pract; 2019 Jun; 152():177-182. PubMed ID: 30946851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strategies to Make Ramadan Fasting Safer in Type 2 Diabetics: A Systematic Review and Network Meta-analysis of Randomized Controlled Trials and Observational Studies.
    Lee SWH; Lee JY; Tan CSS; Wong CP
    Medicine (Baltimore); 2016 Jan; 95(2):e2457. PubMed ID: 26765440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Real-world safety and effectiveness of insulin glargine 300 U/mL in participants with type 2 diabetes who fast during Ramadan: The observational ORION study.
    Hassanein M; Buyukbese MA; Malek R; Pilorget V; Naqvi M; Berthou B; Shaltout I; Kumar Sahay R
    Diabetes Res Clin Pract; 2020 Aug; 166():108189. PubMed ID: 32360709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of empagliflozin in patients with type 2 diabetes during Ramadan on volume status, ketonaemia, and hypoglycaemia.
    Goh KG; Zakaria MH; Raja Azwan RN; Bhajan Singh KK; Badrul Hisham MH; Hussein Z
    Diabetes Metab Syndr; 2023 Jan; 17(1):102680. PubMed ID: 36473336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patterns of Diabetes Care Among People with Type 1 Diabetes During Ramadan: An International Prospective Study (DAR-MENA T1DM).
    Al Awadi FF; Echtay A; Al Arouj M; Sabir Ali S; Shehadeh N; Al Shaikh A; Djaballah K; Dessapt-Baradez C; Omar Abu-Hijleh M; Bennakhi A; El Hassan Gharbi M; El Sayed El Hadidy K; Abdul Kareem Khazaal F; Hassanein MM
    Adv Ther; 2020 Apr; 37(4):1550-1563. PubMed ID: 32144714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CREED study: Hypoglycaemia during Ramadan in individuals with Type 2 diabetes mellitus from three continents.
    Jabbar A; Hassanein M; Beshyah SA; Boye KS; Yu M; Babineaux SM
    Diabetes Res Clin Pract; 2017 Oct; 132():19-26. PubMed ID: 28783529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of provision of optimum diabetes care on the safety of fasting in Ramadan in adult and adolescent patients with type 1 diabetes mellitus.
    Alawadi F; Alsaeed M; Bachet F; Bashier A; Abdulla K; Abuelkheir S; Rashid F; Abdulaziz Bin Hussain A; Abdelgadir E; Alsayyah F; Elsayed M; Hassanein M
    Diabetes Res Clin Pract; 2020 Nov; 169():108466. PubMed ID: 32971155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ramadan Education and Awareness in Diabetes (READ) programme for Muslims with Type 2 diabetes who fast during Ramadan.
    Bravis V; Hui E; Salih S; Mehar S; Hassanein M; Devendra D
    Diabet Med; 2010 Mar; 27(3):327-31. PubMed ID: 20536496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcome of focused pre-Ramadan education on metabolic and glycaemic parameters in patients with type 2 diabetes mellitus.
    El Toony LF; Hamad DA; Omar OM
    Diabetes Metab Syndr; 2018 Sep; 12(5):761-767. PubMed ID: 29729978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vildagliptin therapy and hypoglycaemia in Muslim type 2 diabetes patients during Ramadan.
    Devendra D; Gohel B; Bravis V; Hui E; Salih S; Mehar S; Hassanein M
    Int J Clin Pract; 2009 Oct; 63(10):1446-50. PubMed ID: 19678856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Type 2 diabetes patient's perspective on Ramadan fasting: a qualitative study.
    Lee JY; Wong CP; Tan CSS; Nasir NH; Lee SWH
    BMJ Open Diabetes Res Care; 2017; 5(1):e000365. PubMed ID: 28761651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Higher HbA1c was observed in young people with diabetes who fasted during COVID-19 pandemic lockdown of 2020 Ramadan in Bangladesh - A Post Ramadan survey.
    Zabeen B; Ahmed B; Nahar J; Tayyeb S; Islam N; Mohsin F; Azad K
    Diabetes Res Clin Pract; 2022 Apr; 186():109812. PubMed ID: 35301071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tolerability of canagliflozin in patients with type 2 diabetes mellitus fasting during Ramadan: Results of the Canagliflozin in Ramadan Tolerance Observational Study (CRATOS).
    Hassanein M; Echtay A; Hassoun A; Alarouj M; Afandi B; Poladian R; Bennakhi A; Nazar M; Bergmans P; Keim S; Hamilton G; Azar ST
    Int J Clin Pract; 2017 Oct; 71(10):. PubMed ID: 28851109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Telemonitoring in fasting individuals with Type 2 Diabetes Mellitus during Ramadan: A prospective, randomised controlled study.
    Lee JY; Wong CP; Tan CSS; Nasir NH; Lee SWH
    Sci Rep; 2017 Aug; 7(1):10119. PubMed ID: 28860546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of empagliflozin in people with type 2 diabetes during Ramadan fasting.
    Yousuf S; Ahmedani MY
    Diabetes Metab Syndr; 2022 Nov; 16(11):102633. PubMed ID: 36279701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.